Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 8931-230
Fax: +49 (0)711 - 8931-323
send an Email


Coagulation factor V and thrombophilia: Background and mechanisms

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

Haemostasis, vascular biology, and infectious agents - Thrombophilia and anticoaulant pathway

Issue: 2007: 98/3 (Sep) pp. 483-704
Pages: 530-542

Coagulation factor V and thrombophilia: Background and mechanisms

Kenneth Segers 1, Björn Dahlbäck 2, Gerry A. F. Nicolaes1
1 Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands; 2 Department of Laboratory Medicine, Clinical Chemistry, Lund University, Wallenberg Laboratory, University Hospital, Malmö, Sweden


thrombosis, thrombophilia, coagulation, FactorV, protein C pathway


Human coagulation factorV (FV) is an essential coagulation protein with functions in both the pro- and anticoagulant pathways. Failure to express and control FV functions can either lead to bleeding, or to thromboembolic disease. Both events may develop into a life-threatening condition. Since the first description of APC resistance,and in particular the description of the so-called factorVLeiden mutation, in which a prominent activated protein C cleavage site in FV has been abolished through a mutation in the FV gene,FV has been in the center of attention of thrombosis research. In this review we describe how the functions of FV are expressed and regulated and provide an extensive description of the role that FV plays in the etiology of thromboembolic disease.

You may also be interested in...

N. Bauer, A. Moritz

Tierärztliche Praxis Kleintiere 2008 36 4: 235-246

S. Moll

Hämostaseologie 2007 27 3: 191-200

M. Urooj Zafar 1, Michael E. Farkouh 1, Julio Osende 1, Daichi Shimbo 1, Stella Palencia 1, Julia Crook 2, Robert Leadley 3, Valentin Fuster 1, James H. Chesebro2

Thromb Haemost 2007 97 3: 487-492